Iran ranks 5th in Asia and 1st in the region in biotechnology, with 1,480 knowledge-based companies and 1,000+ biotech products across key sectors.
Tehran – IRNA: Iran has secured the fifth position in Asia in terms of the number of published research papers in the field of biotechnology, while also ranking first among regional countries, well ahead of Turkey, Saudi Arabia, and Egypt. This achievement highlights Iran’s remarkable progress and leadership in science and technology.
The period between 2000 and 2005 marked a turning point in Iran’s biotechnology sector. During these years, Iran transitioned from focusing solely on training researchers to becoming a producer of knowledge-based products with access to international markets. Institutions such as the Committee for Biosciences and Stem Cell Technologies played a vital role in this transformation, pushing the industry beyond academic papers and theses toward commercialization. This linkage between science and the economy has allowed Iran to better address national needs through biotechnology innovations.
A milestone achievement during this period was the production of Interferon Alpha, the first Iranian biotechnological drug developed for the treatment of hepatitis. This step was regarded as a significant stride toward pharmaceutical self-sufficiency and showcased the capabilities of Iranian specialists in developing advanced therapies.
Thanks to increasing research output and extensive institutional support, Iran has made significant progress in biotechnology. Today, the country is home to 1,480 knowledge-based companies in the fields of biotechnology and health. Moreover, Iran has achieved the eighth position globally in the area of regenerative medicine.
In terms of products, Iran leads the region and ranks fifth in Asia with more than 1,000 biotechnology-based products spanning medical, agricultural, industrial, and environmental applications.
These achievements represent the large-scale production of advanced and sensitive products by domestic experts. They reflect a strong integration of research, innovation, and commercialization, promising a bright future for Iran’s knowledge-based industry. With continuous progress, Iran is expected to further strengthen its role as a regional hub for biotechnology and life sciences innovation.